Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in TLX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 561K | $6.5M | -0.6% | 0.166% | 0.00% |
| 2 | LAZARD ASSET MANAGEMENT LLC | 284K | $3.3M | -2.0% | 0.084% | 0.00% |
| 3 | PORTLAND INVESTMENT COUNSEL INC. | 266K | $3.1M | 0.0% | 0.079% | 0.86% |
| 4 | Private Advisor Group, LLC | 197K | $2.3M | +13.1% | 0.058% | 0.01% |
| 5 | MARSHALL WACE, LLP | 189K | $2.2M | β | 0.056% | 0.00% |
| 6 | MORGAN STANLEY | 166K | $1.9M | +42.5% | 0.049% | 0.00% |
| 7 | Integrated Wealth Concepts LLC | 164K | $1.9M | 0.0% | 0.049% | 0.01% |
| 8 | UBS Group AG | 135K | $1.6M | +317.0% | 0.040% | 0.00% |
| 9 | BLAIR WILLIAM & CO/IL | 123K | $1.4M | β | 0.036% | 0.00% |
| 10 | Raiffeisen Bank International AG | 115K | $1.3M | -11.5% | 0.034% | 0.02% |
| 11 | Quadrature Capital Ltd | 102K | $1.2M | β | 0.030% | 0.01% |
| 12 | JPMORGAN CHASE & CO | 78K | $876K | +35.2% | 0.023% | 0.00% |
| 13 | XY Capital Ltd | 71K | $822K | +468.0% | 0.021% | 0.79% |
| 14 | XTX Topco Ltd | 69K | $793K | +164.5% | 0.020% | 0.01% |
| 15 | Vanguard Personalized Indexing Management, LLC | 59K | $680K | +77.4% | 0.017% | 0.01% |
| 16 | NLB Skladi, upravljanje premozenja, d.o.o. | 58K | $669K | β | 0.017% | 0.03% |
| 17 | Mariner, LLC | 37K | $428K | -14.6% | 0.011% | 0.00% |
| 18 | Capricorn Fund Managers Ltd | 36K | $416K | β | 0.011% | 0.03% |
| 19 | GTS SECURITIES LLC | 36K | $410K | β | 0.011% | 0.01% |
| 20 | JANE STREET GROUP, LLC | 33K | $385K | β | 0.010% | 0.00% |
| 21 | IHT Wealth Management, LLC | 32K | $372K | +29.0% | 0.009% | 0.01% |
| 22 | SummitTX Capital, L.P. | 32K | $365K | β | 0.009% | 0.01% |
| 23 | Portolan Capital Management, LLC | 25K | $293K | -95.3% | 0.007% | 0.01% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 21K | $237K | +71.0% | 0.006% | 0.00% |
| 25 | HSBC HOLDINGS PLC | 16K | $190K | β | 0.005% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TLX β a direct measure of their conviction.
Filings activity in TLX during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | +56% | 0.89% | +0.13 pp | $34M | +41% |
| Q1 2026 | 39 | +0.0% | 0.76% | +0.43 pp | $24M | +189% |
| Q4 2025 | 39 | +44% | 0.33% | +0.09 pp | $8M | +9.0% |
| Q3 2025 | 27 | +23% | 0.24% | +0.11 pp | $8M | +6.6% |
| Q2 2025 | 22 | +214% | 0.13% | +0.12 pp | $7M | +812% |
| Q1 2025 | 7 | +250% | 0.01% | +0.01 pp | $1M | +1290% |
| Q4 2024 | 2 | +100% | 0.00% | β | $0M | β |
| Q2 2024 | 1 | β | β | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.
Quick answers to the most common questions about buying TLX stock.
Based on Q2 2026 13F filings, institutional ownership of Telix Pharmaceuticals Limited stands at 0.9%, held across 61 reporting institutions.
FMR LLC is the largest reported institutional holder of TLX, with approximately 561,206 shares worth $0.01B as of Q2 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of TLX, including JANE STREET GROUP, LLC.
Our composite Smart Money Score for TLX is 63 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
22 institutions opened new positions in TLX during Q2 2026, while 1 fully exited. 33 added to existing positions and 4 trimmed.
TLX institutional ownership rose by 0.13 percentage points quarter-over-quarter, with a net change of +22 holders.
The top 10 institutions account for 73.6% of all reported 13F value in TLX, and the top 25 account for 97.2%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.